These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 18729015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ion channel blockers for the treatment of neuropathic pain.
    Colombo E, Francisconi S, Faravelli L, Izzo E, Pevarello P.
    Future Med Chem; 2010 May; 2(5):803-42. PubMed ID: 21426204
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ion channel modulators and urinary tract function.
    Brading AF, Brain KL.
    Handb Exp Pharmacol; 2011 May; (202):375-93. PubMed ID: 21290236
    [Abstract] [Full Text] [Related]

  • 6. The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?
    Rajkumar R, Mahesh R.
    J Psychopharmacol; 2010 Apr; 24(4):455-69. PubMed ID: 20123937
    [Abstract] [Full Text] [Related]

  • 7. Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases.
    Varga Z, Hajdu P, Panyi G.
    Immunol Lett; 2010 May 04; 130(1-2):19-25. PubMed ID: 20026117
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The pharmacology of mechanogated membrane ion channels.
    Hamill OP, McBride DW.
    Pharmacol Rev; 1996 Jun 04; 48(2):231-52. PubMed ID: 8804105
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological modulation of ion channels and transporters.
    Ravens U, Wettwer E, Hála O.
    Cell Calcium; 2004 Jun 04; 35(6):575-82. PubMed ID: 15110147
    [Abstract] [Full Text] [Related]

  • 12. Emerging drugs for major depressive disorder.
    Kennedy SH, Rizvi SJ.
    Expert Opin Emerg Drugs; 2009 Sep 04; 14(3):439-53. PubMed ID: 19637989
    [Abstract] [Full Text] [Related]

  • 13. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds.
    Xiong Q, Gao Z, Wang W, Li M.
    Trends Pharmacol Sci; 2008 Feb 04; 29(2):99-107. PubMed ID: 18206251
    [Abstract] [Full Text] [Related]

  • 14. Ion channel modulators: new targets and new indications for old targets.
    Priest B, Kaczorowski GJ, Garcia ML.
    Curr Opin Drug Discov Devel; 2006 Sep 04; 9(5):587-94. PubMed ID: 17002219
    [Abstract] [Full Text] [Related]

  • 15. Engineering light-gated ion channels.
    Banghart MR, Volgraf M, Trauner D.
    Biochemistry; 2006 Dec 26; 45(51):15129-41. PubMed ID: 17176035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.
    Tsai SJ.
    Med Hypotheses; 2008 Dec 26; 70(3):548-50. PubMed ID: 17703894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.